Position in GSK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$826,768
-$48,545 QoQ
Shares Held
15,772
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#384
of 1,032 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026F/m Investments LLC holds $52,996,280 across 11 Drug Manufacturers - General names. GSK ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,561 | $29,459,202 | |
| 2 | JNJ |
Johnson & Johnson
|
39,177 | $9,949,782 | |
| 3 | ABBV |
AbbVie Inc.
|
24,521 | $6,170,464 | |
| 4 | AMGN |
Amgen Inc
|
4,809 | $1,741,435 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,103 | $1,388,814 | |
| 6 | PFE |
Pfizer Inc
|
47,630 | $1,146,930 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,674 | $986,109 | |
| 8 | GSK |
GSK plc
This page
|
15,772 | $826,768 |
All Filings in GSK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $826,768 | 15,772 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $875,313 | 15,860 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,171,834 | 44,287 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,006,335 | 46,486 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,834,329 | 47,769 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,738,612 | 44,879 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,539,283 | 45,514 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,571,262 | 38,436 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,237,851 | 32,152 | Shares | Sole | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||